FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3008701660> ?p ?o ?g. }

• W3008701660 abstract "Abstract Background Myeloid derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) are two of the major players involved in the inhibition of anti-tumor immune response in cancer patients, leading to poor prognosis. Selective targeting of myeloid cells has therefore become an attractive therapeutic strategy to relieve immunosuppression and, in this frame, we previously demonstrated that lipid nanocapsules (LNCs) loaded with lauroyl-modified gemcitabine efficiently target monocytic MDSCs in melanoma patients. In this study, we investigated the impact of the physico-chemical characteristics of LNCs, namely size and surface potential, towards immunosuppressive cell targeting. We exploited myeloid cells isolated from glioblastoma patients, which play a relevant role in the immunosuppression, to demonstrate that tailored nanosystems can target not only tumor cells but also tumor-promoting cells, thus constituting an efficient system that could be used to inhibit their function. Results The incorporation of different LNC formulations with a size of 100 nm, carrying overall positive, neutral or negative charge, was evaluated on leukocytes and tumor-infiltrating cells freshly isolated from glioblastoma patients. We observed that the maximum LNC uptake was obtained in monocytes with neutral 100 nm LNCs, while positively charged 100 nm LNCs were more effective on macrophages and tumor cells, maintaining at low level the incorporation by T cells. The mechanism of uptake was elucidated, demonstrating that LNCs are incorporated mainly by caveolae-mediated endocytosis. Conclusions We demonstrated that LNCs can be directed towards immunosuppressive cells by simply modulating their size and charge thus providing a novel approach to exploit nanosystems for anticancer treatment in the frame of immunotherapy." @default.
• W3008701660 created "2020-03-06" @default.
• W3008701660 creator A5010682183 @default.
• W3008701660 creator A5012530314 @default.
• W3008701660 creator A5013518641 @default.
• W3008701660 creator A5023041293 @default.
• W3008701660 creator A5032114885 @default.
• W3008701660 creator A5032466294 @default.
• W3008701660 creator A5040123626 @default.
• W3008701660 creator A5052489243 @default.
• W3008701660 creator A5062104854 @default.
• W3008701660 creator A5070299952 @default.
• W3008701660 creator A5075651922 @default.
• W3008701660 creator A5083710753 @default.
• W3008701660 creator A5087279958 @default.
• W3008701660 date "2020-02-17" @default.
• W3008701660 modified "2023-10-13" @default.
• W3008701660 title "Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules" @default.
• W3008701660 cites W1205374584 @default.
• W3008701660 cites W1612749618 @default.
• W3008701660 cites W1823348626 @default.
• W3008701660 cites W1972767432 @default.
• W3008701660 cites W1981040728 @default.
• W3008701660 cites W1988715014 @default.
• W3008701660 cites W2008039399 @default.
• W3008701660 cites W2061123122 @default.
• W3008701660 cites W2069957298 @default.
• W3008701660 cites W2078057254 @default.
• W3008701660 cites W2083710155 @default.
• W3008701660 cites W2099029222 @default.
• W3008701660 cites W2102284924 @default.
• W3008701660 cites W2104603012 @default.
• W3008701660 cites W2115395064 @default.
• W3008701660 cites W2134891981 @default.
• W3008701660 cites W2138151577 @default.
• W3008701660 cites W2143463421 @default.
• W3008701660 cites W2156204466 @default.
• W3008701660 cites W2280099094 @default.
• W3008701660 cites W2338591330 @default.
• W3008701660 cites W2412158473 @default.
• W3008701660 cites W2428936938 @default.
• W3008701660 cites W2471500324 @default.
• W3008701660 cites W2549204228 @default.
• W3008701660 cites W2569208275 @default.
• W3008701660 cites W2582686270 @default.
• W3008701660 cites W2596414786 @default.
• W3008701660 cites W2615603032 @default.
• W3008701660 cites W2739954294 @default.
• W3008701660 cites W2764291366 @default.
• W3008701660 cites W2767051800 @default.
• W3008701660 cites W2770810616 @default.
• W3008701660 cites W2791477629 @default.
• W3008701660 cites W2793492950 @default.
• W3008701660 cites W2799441834 @default.
• W3008701660 cites W2900889908 @default.
• W3008701660 cites W2904210127 @default.
• W3008701660 cites W2904648046 @default.
• W3008701660 cites W2904803926 @default.
• W3008701660 cites W2905841072 @default.
• W3008701660 cites W2918868904 @default.
• W3008701660 cites W2923186456 @default.
• W3008701660 doi "https://doi.org/10.1186/s12951-020-00589-3" @default.
• W3008701660 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7026969" @default.
• W3008701660 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32066449" @default.
• W3008701660 hasPublicationYear "2020" @default.
• W3008701660 type Work @default.
• W3008701660 sameAs 3008701660 @default.
• W3008701660 citedByCount "27" @default.
• W3008701660 countsByYear W30087016602020 @default.
• W3008701660 countsByYear W30087016602021 @default.
• W3008701660 countsByYear W30087016602022 @default.
• W3008701660 countsByYear W30087016602023 @default.
• W3008701660 crossrefType "journal-article" @default.
• W3008701660 hasAuthorship W3008701660A5010682183 @default.
• W3008701660 hasAuthorship W3008701660A5012530314 @default.
• W3008701660 hasAuthorship W3008701660A5013518641 @default.
• W3008701660 hasAuthorship W3008701660A5023041293 @default.
• W3008701660 hasAuthorship W3008701660A5032114885 @default.
• W3008701660 hasAuthorship W3008701660A5032466294 @default.
• W3008701660 hasAuthorship W3008701660A5040123626 @default.
• W3008701660 hasAuthorship W3008701660A5052489243 @default.
• W3008701660 hasAuthorship W3008701660A5062104854 @default.
• W3008701660 hasAuthorship W3008701660A5070299952 @default.
• W3008701660 hasAuthorship W3008701660A5075651922 @default.
• W3008701660 hasAuthorship W3008701660A5083710753 @default.
• W3008701660 hasAuthorship W3008701660A5087279958 @default.
• W3008701660 hasBestOaLocation W30087016601 @default.
• W3008701660 hasConcept C121608353 @default.
• W3008701660 hasConcept C126322002 @default.
• W3008701660 hasConcept C1491633281 @default.
• W3008701660 hasConcept C155672457 @default.
• W3008701660 hasConcept C171250308 @default.
• W3008701660 hasConcept C179185449 @default.
• W3008701660 hasConcept C185592680 @default.
• W3008701660 hasConcept C192562407 @default.
• W3008701660 hasConcept C203014093 @default.
• W3008701660 hasConcept C204399865 @default.
• W3008701660 hasConcept C2778227246 @default.
• W3008701660 hasConcept C2779282312 @default.
• W3008701660 hasConcept C2780252810 @default.

• next